Ledger.Open graph →
SEC Form D · Amendment · filed May 7, 2024

Atacama Therapeutics, Inc

Offering
$4.7M
Sold
$830K
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WELLESLEY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Joseph Baron · Wellesley, MAExec · DirectorJonathan Reis · Wellesley, MADirectorJoseph Baron · Wellesley, MAExec · DirectorJonathan Reis · Wellesley, MADirectorLarry A. Pierce · Edmonds, WAExec · DirectorNick Seaver · Watertown, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗